Selected research
Industry Research
Veletri Industry Research Report 2026
Market perspective
The global Veletri market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veletri is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veletri is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Veletri is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veletri include Teva Parenteral (US), Sanofi S.A (France), Novartis (Canada), Merck (US), Eli Lilly and Company (US), Pfizer (US), GlaxoSmithKline Plc (UK), Bayer HealthCare Pharmaceuticals (Germany) and YM BioSciences (Canada), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veletri market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veletri Market by Company
Teva Parenteral (US)
Sanofi S.A (France)
Novartis (Canada)
Merck (US)
Eli Lilly and Company (US)
Pfizer (US)
GlaxoSmithKline Plc (UK)
Bayer HealthCare Pharmaceuticals (Germany)
YM BioSciences (Canada)
United Therapeutics Corp (US)
The Novartis Group (Switzerland)
Reata Pharmaceuticals (US)
Nippon Shinyaku (Japan)
Gilead Sciences (US)
Daiichi Sankyo (Japan)
Cipla Limited (India)
Arena Pharmaceuticals (US)
Actelion Pharmaceuticals (Switzerland)
Veletri Segment by Type
Oral Medication
Injection
Veletri Segment by Application
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy
Veletri Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veletri market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veletri and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veletri.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veletri manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veletri by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veletri in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Medication
- Injection
Applications
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
Companies covered
- Teva Parenteral (US)
- Sanofi S.A (France)
- Novartis (Canada)
- Merck (US)
- Eli Lilly and Company (US)
- Pfizer (US)
- GlaxoSmithKline Plc (UK)
- Bayer HealthCare Pharmaceuticals (Germany)
- YM BioSciences (Canada)
- United Therapeutics Corp (US)
- The Novartis Group (Switzerland)
- Reata Pharmaceuticals (US)
- Nippon Shinyaku (Japan)
- Gilead Sciences (US)
- Daiichi Sankyo (Japan)
- Cipla Limited (India)
- Arena Pharmaceuticals (US)
- Actelion Pharmaceuticals (Switzerland)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veletri Market Size (2021-2032)
- 2.2.2 Global Veletri Sales (2021-2032)
- 2.2.3 Global Veletri Market Average Price (2021-2032)
- 2.3 Veletri by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Medication
- 2.3.3 Injection
- 2.4 Veletri by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Hospital Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veletri Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veletri Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Veletri Revenue of Manufacturers (2021-2026)
- 3.4 Global Veletri Average Price by Manufacturers (2021-2026)
- 3.5 Global Veletri Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veletri, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veletri, Product Type & Application
- 3.8 Global Manufacturers of Veletri, Established Date
- 3.9 Global Veletri Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Parenteral (US)
- 4.1.1 Teva Parenteral (US) Company Information
- 4.1.2 Teva Parenteral (US) Business Overview
- 4.1.3 Teva Parenteral (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Parenteral (US) Veletri Product Portfolio
- 4.1.5 Teva Parenteral (US) Recent Developments
- 4.2 Sanofi S.A (France)
- 4.2.1 Sanofi S.A (France) Company Information
- 4.2.2 Sanofi S.A (France) Business Overview
- 4.2.3 Sanofi S.A (France) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi S.A (France) Veletri Product Portfolio
- 4.2.5 Sanofi S.A (France) Recent Developments
- 4.3 Novartis (Canada)
- 4.3.1 Novartis (Canada) Company Information
- 4.3.2 Novartis (Canada) Business Overview
- 4.3.3 Novartis (Canada) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis (Canada) Veletri Product Portfolio
- 4.3.5 Novartis (Canada) Recent Developments
- 4.4 Merck (US)
- 4.4.1 Merck (US) Company Information
- 4.4.2 Merck (US) Business Overview
- 4.4.3 Merck (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck (US) Veletri Product Portfolio
- 4.4.5 Merck (US) Recent Developments
- 4.5 Eli Lilly and Company (US)
- 4.5.1 Eli Lilly and Company (US) Company Information
- 4.5.2 Eli Lilly and Company (US) Business Overview
- 4.5.3 Eli Lilly and Company (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Eli Lilly and Company (US) Veletri Product Portfolio
- 4.5.5 Eli Lilly and Company (US) Recent Developments
- 4.6 Pfizer (US)
- 4.6.1 Pfizer (US) Company Information
- 4.6.2 Pfizer (US) Business Overview
- 4.6.3 Pfizer (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer (US) Veletri Product Portfolio
- 4.6.5 Pfizer (US) Recent Developments
- 4.7 GlaxoSmithKline Plc (UK)
- 4.7.1 GlaxoSmithKline Plc (UK) Company Information
- 4.7.2 GlaxoSmithKline Plc (UK) Business Overview
- 4.7.3 GlaxoSmithKline Plc (UK) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GlaxoSmithKline Plc (UK) Veletri Product Portfolio
- 4.7.5 GlaxoSmithKline Plc (UK) Recent Developments
- 4.8 Bayer HealthCare Pharmaceuticals (Germany)
- 4.8.1 Bayer HealthCare Pharmaceuticals (Germany) Company Information
- 4.8.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
- 4.8.3 Bayer HealthCare Pharmaceuticals (Germany) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer HealthCare Pharmaceuticals (Germany) Veletri Product Portfolio
- 4.8.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
- 4.9 YM BioSciences (Canada)
- 4.9.1 YM BioSciences (Canada) Company Information
- 4.9.2 YM BioSciences (Canada) Business Overview
- 4.9.3 YM BioSciences (Canada) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 YM BioSciences (Canada) Veletri Product Portfolio
- 4.9.5 YM BioSciences (Canada) Recent Developments
- 4.10 United Therapeutics Corp (US)
- 4.10.1 United Therapeutics Corp (US) Company Information
- 4.10.2 United Therapeutics Corp (US) Business Overview
- 4.10.3 United Therapeutics Corp (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 United Therapeutics Corp (US) Veletri Product Portfolio
- 4.10.5 United Therapeutics Corp (US) Recent Developments
- 4.11 The Novartis Group (Switzerland)
- 4.11.1 The Novartis Group (Switzerland) Company Information
- 4.11.2 The Novartis Group (Switzerland) Business Overview
- 4.11.3 The Novartis Group (Switzerland) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 The Novartis Group (Switzerland) Veletri Product Portfolio
- 4.11.5 The Novartis Group (Switzerland) Recent Developments
- 4.12 Reata Pharmaceuticals (US)
- 4.12.1 Reata Pharmaceuticals (US) Company Information
- 4.12.2 Reata Pharmaceuticals (US) Business Overview
- 4.12.3 Reata Pharmaceuticals (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Reata Pharmaceuticals (US) Veletri Product Portfolio
- 4.12.5 Reata Pharmaceuticals (US) Recent Developments
- 4.13 Nippon Shinyaku (Japan)
- 4.13.1 Nippon Shinyaku (Japan) Company Information
- 4.13.2 Nippon Shinyaku (Japan) Business Overview
- 4.13.3 Nippon Shinyaku (Japan) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Nippon Shinyaku (Japan) Veletri Product Portfolio
- 4.13.5 Nippon Shinyaku (Japan) Recent Developments
- 4.14 Gilead Sciences (US)
- 4.14.1 Gilead Sciences (US) Company Information
- 4.14.2 Gilead Sciences (US) Business Overview
- 4.14.3 Gilead Sciences (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Gilead Sciences (US) Veletri Product Portfolio
- 4.14.5 Gilead Sciences (US) Recent Developments
- 4.15 Daiichi Sankyo (Japan)
- 4.15.1 Daiichi Sankyo (Japan) Company Information
- 4.15.2 Daiichi Sankyo (Japan) Business Overview
- 4.15.3 Daiichi Sankyo (Japan) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Daiichi Sankyo (Japan) Veletri Product Portfolio
- 4.15.5 Daiichi Sankyo (Japan) Recent Developments
- 4.16 Cipla Limited (India)
- 4.16.1 Cipla Limited (India) Company Information
- 4.16.2 Cipla Limited (India) Business Overview
- 4.16.3 Cipla Limited (India) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Cipla Limited (India) Veletri Product Portfolio
- 4.16.5 Cipla Limited (India) Recent Developments
- 4.17 Arena Pharmaceuticals (US)
- 4.17.1 Arena Pharmaceuticals (US) Company Information
- 4.17.2 Arena Pharmaceuticals (US) Business Overview
- 4.17.3 Arena Pharmaceuticals (US) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Arena Pharmaceuticals (US) Veletri Product Portfolio
- 4.17.5 Arena Pharmaceuticals (US) Recent Developments
- 4.18 Actelion Pharmaceuticals (Switzerland)
- 4.18.1 Actelion Pharmaceuticals (Switzerland) Company Information
- 4.18.2 Actelion Pharmaceuticals (Switzerland) Business Overview
- 4.18.3 Actelion Pharmaceuticals (Switzerland) Veletri Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Actelion Pharmaceuticals (Switzerland) Veletri Product Portfolio
- 4.18.5 Actelion Pharmaceuticals (Switzerland) Recent Developments
5 Global Veletri Market Scenario by Region
- 5.1 Global Veletri Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veletri Sales by Region: 2021-2032
- 5.2.1 Global Veletri Sales by Region: 2021-2026
- 5.2.2 Global Veletri Sales by Region: 2027-2032
- 5.3 Global Veletri Revenue by Region: 2021-2032
- 5.3.1 Global Veletri Revenue by Region: 2021-2026
- 5.3.2 Global Veletri Revenue by Region: 2027-2032
- 5.4 North America Veletri Market Facts & Figures by Country
- 5.4.1 North America Veletri Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veletri Sales by Country (2021-2032)
- 5.4.3 North America Veletri Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Veletri Market Facts & Figures by Country
- 5.5.1 Europe Veletri Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veletri Sales by Country (2021-2032)
- 5.5.3 Europe Veletri Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Veletri Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veletri Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veletri Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veletri Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veletri Market Facts & Figures by Country
- 5.7.1 South America Veletri Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veletri Sales by Country (2021-2032)
- 5.7.3 South America Veletri Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Veletri Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veletri Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veletri Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veletri Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Veletri Sales by Type (2021-2032)
- 6.1.1 Global Veletri Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Veletri Sales Market Share by Type (2021-2032)
- 6.2 Global Veletri Revenue by Type (2021-2032)
- 6.2.1 Global Veletri Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veletri Revenue Market Share by Type (2021-2032)
- 6.3 Global Veletri Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veletri Sales by Application (2021-2032)
- 7.1.1 Global Veletri Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Veletri Sales Market Share by Application (2021-2032)
- 7.2 Global Veletri Revenue by Application (2021-2032)
- 7.2.1 Global Veletri Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veletri Revenue Market Share by Application (2021-2032)
- 7.3 Global Veletri Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veletri Value Chain Analysis
- 8.1.1 Veletri Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veletri Production Mode & Process
- 8.2 Veletri Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veletri Distributors
- 8.2.3 Veletri Customers
9 Global Veletri Analyzing Market Dynamics
- 9.1 Veletri Industry Trends
- 9.2 Veletri Industry Drivers
- 9.3 Veletri Industry Opportunities and Challenges
- 9.4 Veletri Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst